1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide

C89H90F7N9O7S — CID 161238200

IUPAC1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide
SMILESCCOC(=O)[C@H]1C2C=CC(C2)[C@H]1NC(=O)c1nn(-c2ccc(F)cc2F)c2c1CCCCC2Cc1cccc(F)c1.C[C@H](NS(=O)(=O)/C=C/c1nn(C)c2c1CCCCC2Cc1ccc(F)cc1)c1ccccc1.O=C(N[C@@H]1c2ccccc2C[C@@H]1O)c1nn(-c2ccc(F)cc2F)c2c1CCCCC2Cc1cccc(F)c1
InChIInChI=1S/C32H32F3N3O3.C31H28F3N3O2.C26H30FN3O2S/c1-2-41-32(40)27-19-10-11-20(16-19)28(27)36-31(39)29-24-9-4-3-7-21(14-18-6-5-8-22(33)15-18)30(24)38(37-29)26-13-12-23(34)17-25(26)35;32-21-9-5-6-18(15-21)14-20-8-2-4-11-24-29(36-37(30(20)24)26-13-12-22(33)17-25(26)34)31(39)35-28-23-10-3-1-7-19(23)16-27(28)38;1-19(21-8-4-3-5-9-21)29-33(31,32)17-16-25-24-11-7-6-10-22(26(24)30(2)28-25)18-20-12-14-23(27)15-13-20/h5-6,8,10-13,15,17,19-21,27-28H,2-4,7,9,14,16H2,1H3,(H,36,39);1,3,5-7,9-10,12-13,15,17,20,27-28,38H,2,4,8,11,14,16H2,(H,35,39);3-5,8-9,12-17,19,22,29H,6-7,10-11,18H2,1-2H3/b;;17-16+/t19?,20?,21?,27-,28+;20?,27-,28+;19-,22?/m000/s1
InChIKeyUZQOUIYHLGRCKG-CUFLHQLOSA-N
MW1562.81 g/mol
LogP16.82
Rot. Bonds19

About 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide

1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide (PubChem CID 161238200) has the molecular formula C89H90F7N9O7S and a molecular weight of 1562.81 g/mol. Its IUPAC name is 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide.

Molecular Properties

Compound Name1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide
PubChem CID161238200
Molecular FormulaC89H90F7N9O7S
Molecular Weight1562.81 g/mol
Exact Mass1561.66
IUPAC Name1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide
SMILESCCOC(=O)[C@H]1C2C=CC(C2)[C@H]1NC(=O)c1nn(-c2ccc(F)cc2F)c2c1CCCCC2Cc1cccc(F)c1.C[C@H](NS(=O)(=O)/C=C/c1nn(C)c2c1CCCCC2Cc1ccc(F)cc1)c1ccccc1.O=C(N[C@@H]1c2ccccc2C[C@@H]1O)c1nn(-c2ccc(F)cc2F)c2c1CCCCC2Cc1cccc(F)c1
InChIInChI=1S/C32H32F3N3O3.C31H28F3N3O2.C26H30FN3O2S/c1-2-41-32(40)27-19-10-11-20(16-19)28(27)36-31(39)29-24-9-4-3-7-21(14-18-6-5-8-22(33)15-18)30(24)38(37-29)26-13-12-23(34)17-25(26)35;32-21-9-5-6-18(15-21)14-20-8-2-4-11-24-29(36-37(30(20)24)26-13-12-22(33)17-25(26)34)31(39)35-28-23-10-3-1-7-19(23)16-27(28)38;1-19(21-8-4-3-5-9-21)29-33(31,32)17-16-25-24-11-7-6-10-22(26(24)30(2)28-25)18-20-12-14-23(27)15-13-20/h5-6,8,10-13,15,17,19-21,27-28H,2-4,7,9,14,16H2,1H3,(H,36,39);1,3,5-7,9-10,12-13,15,17,20,27-28,38H,2,4,8,11,14,16H2,(H,35,39);3-5,8-9,12-17,19,22,29H,6-7,10-11,18H2,1-2H3/b;;17-16+/t19?,20?,21?,27-,28+;20?,27-,28+;19-,22?/m000/s1
InChIKeyUZQOUIYHLGRCKG-CUFLHQLOSA-N
XLogP16.82
TPSA204.36 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds19
Heavy Atoms113
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001562.81
LogP ≤ 516.82
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide?
The IUPAC name of 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide (CID 161238200) is 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide.
What is the SMILES notation for 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide?
The canonical SMILES for 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide is CCOC(=O)[C@H]1C2C=CC(C2)[C@H]1NC(=O)c1nn(-c2ccc(F)cc2F)c2c1CCCCC2Cc1cccc(F)c1.C[C@H](NS(=O)(=O)/C=C/c1nn(C)c2c1CCCCC2Cc1ccc(F)cc1)c1ccccc1.O=C(N[C@@H]1c2ccccc2C[C@@H]1O)c1nn(-c2ccc(F)cc2F)c2c1CCCCC2Cc1cccc(F)c1.
What is the InChIKey of 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide?
The InChIKey is UZQOUIYHLGRCKG-CUFLHQLOSA-N. The full InChI is InChI=1S/C32H32F3N3O3.C31H28F3N3O2.C26H30FN3O2S/c1-2-41-32(40)27-19-10-11-20(16-19)28(27)36-31(39)29-24-9-4-3-7-21(14-18-6-5-8-22(33)15-18)30(24)38(37-29)26-13-12-23(34)17-25(26)35;32-21-9-5-6-18(15-21)14-20-8-2-4-11-24-29(36-37(30(20)24)26-13-12-22(33)17-25(26)34)31(39)35-28-23-10-3-1-7-19(23)16-27(28)38;1-19(21-8-4-3-5-9-21)29-33(31,32)17-16-25-24-11-7-6-10-22(26(24)30(2)28-25)18-20-12-14-23(27)15-13-20/h5-6,8,10-13,15,17,19-21,27-28H,2-4,7,9,14,16H2,1H3,(H,36,39);1,3,5-7,9-10,12-13,15,17,20,27-28,38H,2,4,8,11,14,16H2,(H,35,39);3-5,8-9,12-17,19,22,29H,6-7,10-11,18H2,1-2H3/b;;17-16+/t19?,20?,21?,27-,28+;20?,27-,28+;19-,22?/m000/s1.
What are the key properties of 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide?
1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide has a molecular weight of 1562.81 g/mol, XLogP of 16.82, 19 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carboxamide;ethyl (2S,3R)-3-[[1-(2,4-difluorophenyl)-8-[(3-fluorophenyl)methyl]-5,6,7,8-tetrahydro-4H-cyclohepta[d]pyrazole-3-carbonyl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxylate;(E)-2-[8-[(4-fluorophenyl)methyl]-1-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]pyrazol-3-yl]-N-[(1S)-1-phenylethyl]ethenesulfonamide is sourced from PubChem (CID 161238200), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).